ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)
China
· Delayed Price · Currency is CNY 38.80
+0.50 (1.31%)
Mar 10, 2026, 3:00 PM CST
ChengDu ShengNuo Biotec Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Market Capitalization | 6,107 | 5,948 | 2,886 | 3,158 | 1,778 | 2,929 | Upgrade
|
| Market Cap Growth | 114.20% | 106.10% | -8.63% | 77.68% | -39.31% | - | Upgrade
|
| Enterprise Value | 6,380 | 6,221 | 3,054 | 3,124 | 1,495 | 2,550 | Upgrade
|
| Last Close Price | 38.80 | 37.79 | 18.27 | 19.91 | 11.14 | 18.17 | Upgrade
|
| PE Ratio | 36.95 | 35.87 | 57.69 | 44.90 | 27.57 | 47.82 | Upgrade
|
| Forward PE | 22.56 | 23.96 | 20.17 | 34.71 | - | - | Upgrade
|
| PS Ratio | 8.24 | 8.02 | 6.33 | 7.26 | 4.49 | 7.58 | Upgrade
|
| PB Ratio | 5.92 | 5.76 | 3.14 | 3.59 | 2.15 | 3.73 | Upgrade
|
| P/TBV Ratio | 6.42 | 6.25 | 3.29 | 3.74 | 2.25 | 3.91 | Upgrade
|
| P/OCF Ratio | - | - | 114.18 | 37.25 | 18.59 | 55.88 | Upgrade
|
| EV/Sales Ratio | 8.61 | 8.39 | 6.70 | 7.18 | 3.78 | 6.60 | Upgrade
|
| EV/EBITDA Ratio | 27.21 | 26.54 | 30.65 | 29.77 | 16.84 | 30.48 | Upgrade
|
| EV/EBIT Ratio | 31.77 | 30.97 | 46.23 | 40.42 | 22.99 | 38.80 | Upgrade
|
| Debt / Equity Ratio | 0.55 | 0.55 | 0.53 | 0.30 | 0.12 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | 2.42 | 2.42 | 4.79 | 2.49 | 1.14 | 0.39 | Upgrade
|
| Net Debt / Equity Ratio | 0.27 | 0.27 | 0.27 | -0.01 | -0.33 | -0.48 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.17 | 1.17 | 2.44 | -0.07 | -3.04 | -4.53 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -1.10 | 0.04 | 6.70 | 32.07 | Upgrade
|
| Asset Turnover | - | - | 0.31 | 0.36 | 0.38 | 0.50 | Upgrade
|
| Inventory Turnover | - | - | 0.81 | 0.99 | 1.20 | 1.16 | Upgrade
|
| Quick Ratio | - | - | 0.69 | 1.64 | 2.29 | 3.28 | Upgrade
|
| Current Ratio | - | - | 1.32 | 2.53 | 2.96 | 4.01 | Upgrade
|
| Return on Equity (ROE) | 17.01% | 17.01% | 5.54% | 8.24% | 8.00% | 10.02% | Upgrade
|
| Return on Assets (ROA) | - | - | 2.79% | 3.98% | 3.94% | 5.30% | Upgrade
|
| Return on Invested Capital (ROIC) | 13.57% | 14.36% | 5.26% | 9.49% | 12.03% | 15.28% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 6.00% | 7.20% | 7.40% | 8.30% | Upgrade
|
| Earnings Yield | 2.72% | 2.79% | 1.73% | 2.23% | 3.63% | 2.09% | Upgrade
|
| FCF Yield | - | - | -7.70% | -6.12% | -2.26% | -0.40% | Upgrade
|
| Dividend Yield | 0.17% | - | 0.55% | 0.72% | 1.15% | 0.84% | Upgrade
|
| Payout Ratio | - | - | 68.30% | 41.49% | 41.59% | 0.04% | Upgrade
|
| Buyback Yield / Dilution | -42.07% | 0.77% | -0.22% | -2.03% | -10.21% | -20.10% | Upgrade
|
| Total Shareholder Return | -41.90% | 0.77% | 0.33% | -1.31% | -9.06% | -19.26% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.